Skip to main content
editor@jprims.in
9343055451
e-ISSN: 3049-1681
Journal of Pharmaceutical Research and Integrated Medical Sciences

Journal of Pharmaceutical Research and Integrated Medical Sciences

Keyword

In-Vitro Antiglyction Activity

Explore 1 research publication tagged with this keyword

1Publications
2Authors
1Years

Publications Tagged with "In-Vitro Antiglyction Activity"

1 publication found

2026

1 publication

Hypoglycemic Effect of Methanolic Extract of Annona Squmosa L. (Seeds) on Streptozotocin-Induced Diabetes in Rats

Bhulaxmi and Arpan Kumar Tripathi
11/17/2026
pp. 1-26

The purity, safety, and long-term therapeutic efficacy of Annona squamosa L. seed extract in the treatment of diabetes were thoroughly assessed. Petroleum ether defatting and Soxhlet methanolic extraction came with the establishment of physicochemical standards (ash values). High levels of total phenolic content (TPC) and total flavonoid content (TFC), which provided notable in vitro antioxidant and anti-glycation properties, were shown by quantitative phytochemical screening. According to OECD Guideline 420 (Fixed Dose Procedure), acute oral toxicity testing verified that the extract has a broad margin of safety, showing no evidence of acute toxicity or fatality up to the highest suggested limit dose. Oral administration of Annona squamosa L. seed extract (200 mg/kg and 400 mg/kg) significantly decreased fasting blood glucose levels and reversed progressive body weight loss in an 8-week in vivo study on streptozotocin (STZ, 50–55 mg/kg)-induced diabetic Wistar rats when compared to untreated diabetic controls. The therapeutic efficacy of the 400 mg/kg dose was similar to that of normal Glibenclamide (10 mg/kg). To sum up, Annona squamosa L. seed methanolic extract is a safe, flavonoid-rich, antioxidant-rich substance that successfully reduces glycation, hyperglycemia, and weight loss in people with chronic diabetes.

Keyword Statistics
Total Publications:1
Years Active:1
Latest Publication:2026
Contributing Authors:2